{
    "doc_id": "v1_data/DeepSeek-V3_gpqa-diamond_responses_87.json",
    "metadata": {
        "model_id": "deepseek-ai/DeepSeek-V3",
        "correct_answer": "A"
    },
    "raw_text": {
        "question": "You tag the inner capsid proteins of rotavirus with a GFP and deliver them to mice via oral gavage. By in vivo imaging, you observe that some of the fluorescence was destroyed by the stomach acid, and some were entangled in the intestinal mucus before they reached the secondary lymphoid organs. You identify the fluorescent Peyer patches and isolate the proliferating cell population. You sequence their variable heavy chain gene and observe high variability. Which process is taking place?\nA. somatic hypermutation\nB. complement activation\nC. VDJ recombination\nD. class switching recombination",
        "response": "The process taking place in this scenario is **A. somatic hypermutation**.\n\n### Explanation:\n1. **Context**: You are observing proliferating cells in Peyer patches, which are secondary lymphoid organs in the gut-associated lymphoid tissue (GALT). These cells are likely B cells responding to the rotavirus antigens delivered via oral gavage.\n\n2. **High variability in the variable heavy chain gene**: This indicates that the B cells are undergoing changes in their immunoglobulin genes to improve antigen binding affinity.\n\n3. **Somatic hypermutation**: This is a process that occurs in B cells during their maturation in germinal centers (e.g., in Peyer patches). It introduces point mutations into the variable regions of immunoglobulin genes, leading to increased diversity and affinity for the antigen.\n\n4. **Other options**:\n   - **B. Complement activation**: This is part of the innate immune response and does not involve changes in immunoglobulin genes.\n   - **C. VDJ recombination**: This occurs during B cell development in the bone marrow to generate the initial diversity of the B cell receptor, not during the secondary immune response in Peyer patches.\n   - **D. Class switching recombination**: This changes the constant region of the immunoglobulin to alter the antibody class (e.g., from IgM to IgG), but it does not directly increase variability in the variable region.\n\nThus, the correct answer is **A. somatic hypermutation**."
    },
    "nodes": [
        {
            "id": "ctx0",
            "annotation": false,
            "start": 0,
            "end": 100,
            "label": "context",
            "text": "You tag the inner capsid proteins of rotavirus with a GFP and deliver them to mice via oral gavage. ",
            "source": "question"
        },
        {
            "id": "ctx1",
            "annotation": false,
            "start": 100,
            "end": 296,
            "label": "context",
            "text": "By in vivo imaging, you observe that some of the fluorescence was destroyed by the stomach acid, and some were entangled in the intestinal mucus before they reached the secondary lymphoid organs. ",
            "source": "question"
        },
        {
            "id": "ctx2",
            "annotation": false,
            "start": 296,
            "end": 386,
            "label": "context",
            "text": "You identify the fluorescent Peyer patches and isolate the proliferating cell population. ",
            "source": "question"
        },
        {
            "id": "ctx3",
            "annotation": false,
            "start": 386,
            "end": 461,
            "label": "context",
            "text": "You sequence their variable heavy chain gene and observe high variability. ",
            "source": "question"
        },
        {
            "id": "ctx4",
            "annotation": false,
            "start": 461,
            "end": 492,
            "label": "context",
            "text": "Which process is taking place?\n",
            "source": "question"
        },
        {
            "id": "ctx5",
            "annotation": false,
            "start": 492,
            "end": 595,
            "label": "context",
            "text": "A. somatic hypermutation\nB. complement activation\nC. VDJ recombination\nD. class switching recombination",
            "source": "question"
        },
        {
            "id": "resp0",
            "annotation": false,
            "start": 0,
            "end": 76,
            "label": "reasoning",
            "text": "The process taking place in this scenario is **A. somatic hypermutation**.\n\n",
            "source": "response"
        },
        {
            "id": "resp1",
            "annotation": false,
            "start": 76,
            "end": 93,
            "label": "restatement",
            "text": "### Explanation:\n",
            "source": "response"
        },
        {
            "id": "resp2",
            "annotation": false,
            "start": 93,
            "end": 247,
            "label": "fact",
            "text": "1. **Context**: You are observing proliferating cells in Peyer patches, which are secondary lymphoid organs in the gut-associated lymphoid tissue (GALT). ",
            "source": "response"
        },
        {
            "id": "resp3",
            "annotation": false,
            "start": 247,
            "end": 343,
            "label": "reasoning",
            "text": "These cells are likely B cells responding to the rotavirus antigens delivered via oral gavage.\n\n",
            "source": "response"
        },
        {
            "id": "resp4",
            "annotation": false,
            "start": 343,
            "end": 524,
            "label": "reasoning",
            "text": "2. **High variability in the variable heavy chain gene**: This indicates that the B cells are undergoing changes in their immunoglobulin genes to improve antigen binding affinity.\n\n",
            "source": "response"
        },
        {
            "id": "resp5",
            "annotation": false,
            "start": 524,
            "end": 665,
            "label": "fact",
            "text": "3. **Somatic hypermutation**: This is a process that occurs in B cells during their maturation in germinal centers (e.g., in Peyer patches). ",
            "source": "response"
        },
        {
            "id": "resp6",
            "annotation": false,
            "start": 665,
            "end": 808,
            "label": "fact",
            "text": "It introduces point mutations into the variable regions of immunoglobulin genes, leading to increased diversity and affinity for the antigen.\n\n",
            "source": "response"
        },
        {
            "id": "resp7",
            "annotation": false,
            "start": 808,
            "end": 833,
            "label": "planning",
            "text": "4. **Other options**:\n   ",
            "source": "response"
        },
        {
            "id": "resp8",
            "annotation": false,
            "start": 833,
            "end": 965,
            "label": "fact",
            "text": "- **B. Complement activation**: This is part of the innate immune response and does not involve changes in immunoglobulin genes.\n   ",
            "source": "response"
        },
        {
            "id": "resp9",
            "annotation": false,
            "start": 965,
            "end": 1170,
            "label": "fact",
            "text": "- **C. VDJ recombination**: This occurs during B cell development in the bone marrow to generate the initial diversity of the B cell receptor, not during the secondary immune response in Peyer patches.\n   ",
            "source": "response"
        },
        {
            "id": "resp10",
            "annotation": false,
            "start": 1170,
            "end": 1389,
            "label": "fact",
            "text": "- **D. Class switching recombination**: This changes the constant region of the immunoglobulin to alter the antibody class (e.g., from IgM to IgG), but it does not directly increase variability in the variable region.\n\n",
            "source": "response"
        },
        {
            "id": "resp11",
            "annotation": false,
            "start": 1389,
            "end": 1446,
            "label": "conclusion",
            "text": "Thus, the correct answer is **A. somatic hypermutation**.",
            "source": "response"
        }
    ],
    "edges": [
        {
            "id": "e0",
            "from_node_id": "ctx3",
            "to_node_id": "resp0",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e1",
            "from_node_id": "resp0",
            "to_node_id": "resp1",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e2",
            "from_node_id": "resp1",
            "to_node_id": "resp2",
            "label": "reason:fact-detail"
        },
        {
            "id": "e3",
            "from_node_id": "resp2",
            "to_node_id": "resp3",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e4",
            "from_node_id": "resp2",
            "to_node_id": "resp4",
            "label": "evaluate:support"
        },
        {
            "id": "e5",
            "from_node_id": "resp3",
            "to_node_id": "resp4",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e6",
            "from_node_id": "resp4",
            "to_node_id": "resp5",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e7",
            "from_node_id": "resp5",
            "to_node_id": "resp6",
            "label": "reason:fact-detail"
        },
        {
            "id": "e8",
            "from_node_id": "resp4",
            "to_node_id": "resp7",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e9",
            "from_node_id": "resp5",
            "to_node_id": "resp7",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e10",
            "from_node_id": "resp6",
            "to_node_id": "resp7",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e11",
            "from_node_id": "resp4",
            "to_node_id": "resp8",
            "label": "reason:fact-detail"
        },
        {
            "id": "e12",
            "from_node_id": "resp7",
            "to_node_id": "resp8",
            "label": "reason:plan-step"
        },
        {
            "id": "e13",
            "from_node_id": "resp7",
            "to_node_id": "resp9",
            "label": "reason:plan-step"
        },
        {
            "id": "e14",
            "from_node_id": "resp7",
            "to_node_id": "resp10",
            "label": "reason:plan-step"
        },
        {
            "id": "e15",
            "from_node_id": "resp9",
            "to_node_id": "resp10",
            "label": "reason:fact-detail"
        },
        {
            "id": "e16",
            "from_node_id": "resp0",
            "to_node_id": "resp11",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e17",
            "from_node_id": "resp4",
            "to_node_id": "resp11",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e18",
            "from_node_id": "resp7",
            "to_node_id": "resp11",
            "label": "reason:plan-step"
        }
    ]
}